Internal Medicine, Medical Oncology · Saint Louis, MO
NPI
1750731337
Since 2016
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
10 Barnes West Dr, Div Im Medical Oncology, Mob #2
Saint Louis, MO, 63141
Phone (800) 647-2098
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.4M
69,585 services
Medicare patients, 2024
431
Average age 69
Drug cost, 2024
$887K
1,372 prescriptions
Company payments, 2025
$17K
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Omar H Butt was code J1453 (injection, fosaprepitant, 1 mg), 8,550 times for 33 patients. In total Omar H Butt billed 69,585 services in 142 codes, and Medicare paid $1.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1453 Injection, fosaprepitant, 1 mg | Office | 8,550 | 33 | $0.10 | $885 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 4,400 | 15 | $44.40 | $195K |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 4,100 | 12 | $0.05 | $219 |
| J0897 Injection, denosumab, 1 mg | Office | 2,520 | 18 | $19.81 | $50K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,300 | 83 | $0.09 | $115 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 930 | 61 | $0.78 | $727 |
| J0640 Injection, leucovorin calcium, per 50 mg | Office | 579 | 21 | $3.76 | $2,175 |
| J9190 Injection, fluorouracil, 500 mg | Office | 404 | 25 | $2.42 | $979 |
| J2506 Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | Office | 264 | 17 | $73.42 | $19K |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 260 | 19 | $0.27 | $71.44 |
| 96413 Chemotherapy Administration | Office | 242 | 170 | $89.15 | $22K |
| 96367 Intravenous Infusion, Hydration | Office | 206 | 92 | $20.38 | $4,198 |
| 96375 Injection Administration | Office | 189 | 94 | $11.38 | $2,151 |
| J9201 Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | Office | 174 | 13 | $2.72 | $473 |
| J9206 Injection, irinotecan, 20 mg | Office | 166 | 11 | $2.16 | $359 |
By year: 2022 $860K for 50,214 services; 2023 $2.5M for 131,585 services; 2024 $1.4M for 69,585 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 61 | 28 | $8.65 | $528 |
Medicare prescription drug claims, 2024
In 2024, the drug Omar H Butt prescribed most often to Medicare patients was Dexamethasone, with 280 prescriptions and refills. In total Omar H Butt wrote 1,372 Medicare prescriptions that cost $887K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dexamethasone Generic | 280 | 346 | 85 | $5,783 |
| Levetiracetam Generic | 140 | 267 | 40 | $5,911 |
| Ondansetron Hcl Generic | 99 | 99 | 46 | $1,300 |
| Prochlorperazine Maleate Generic | 66 | 66 | 46 | $1,872 |
| Lamotrigine Generic | 60 | 111 | 16 | $774 |
| Gleostine Lomustine | 57 | 69 | 18 | $56K |
| Pentoxifylline Generic | 46 | 58 | 11 | $1,148 |
| Eliquis Apixaban | 33 | 34 | Under 11 | $19K |
| Atorvastatin Calcium Generic | 30 | 44 | Under 11 | $325 |
| Lacosamide Generic | 29 | 29 | Under 11 | $932 |
| Quetiapine Fumarate Generic | 28 | 34 | 11 | $254 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 28 | 44 | Under 11 | $314 |
| Zonisamide Generic | 27 | 41 | Under 11 | $484 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 26 | 27 | 13 | $89.76 |
| Prednisone Generic | 25 | 28 | 14 | $56.82 |
Brand drugs: 137 claims; generic drugs: 1,235 claims; opioid claims: 26.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Omar H Butt $17K ($17K in general payments such as food, travel and fees) from 6 companies. The largest payer was Novocure Inc. with $15K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.